Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
ODM-201 CRYSTALLINE FORM, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION THEREOF
Document Type and Number:
WIPO Patent Application WO/2019/028689
Kind Code:
A1
Abstract:
The present invention relates to a crystalline form of N-((S)-1-(3-(3-chloro-4-cyanophenyl)-1H-pyrazol-1-yl)prop-2-yl)-5-(1-hydroxylethyl)-1H-pyrazole-3-carboxamide (namely, ODM-201). The ODM-201 crystalline form of the present invention has one or more improved properties compared to known ODM-201. The present invention further relates to a method for preparing the ODM-201 crystalline form, a pharmaceutical composition thereof, and a use thereof in the preparation of a medicament for the treatment of nuclear receptor, specifically steroid receptor, and more specifically androgen receptor (AR)-dependent diseases and conditions.

Inventors:
SHENG XIAOHONG (CN)
SHENG XIAOXIA (CN)
Application Number:
PCT/CN2017/096547
Publication Date:
February 14, 2019
Filing Date:
August 09, 2017
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
SOLIPHARMA LLC (CN)
International Classes:
C07D231/14; A61K31/4155; A61P35/00
Domestic Patent References:
WO2016120530A12016-08-04
WO2018036558A12018-03-01
Download PDF: